| Authors: |
Rascol O; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Ory-Magne F; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Meissner WG; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.; Department of Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand., Maltête D; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, UMR 1239, Rouen University Hospital, University of Rouen, INSERM, Rouen, France., Defebvre L; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France., Azulay JP; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Pathology of Movement, Parkinson Expert Centre, UMR7289, AP-HM-Timone Hospital, University of Aix-Marseille, CNRS, Marseille, France., Thobois S; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Lyon Neuroscience Research Centre, PATH-PARK Team U1028, UMR5292, Bron, France.; Hospital Pierre Wertheimer, Hospices Civils de Lyon, University Lyon 1, INSERM, CNRS, Lyon, France., Houeto JL; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, U 1094 EpiMaCT, CHU Limoges, INSERM, University of Limoges, Limoges, France., Thalamas C; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Sommet A; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Geny C; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Geriatrics, Parkinson Expert Centre, Clinical Investigation Centre CIC 1411, CHU Montpellier, INSERM, Montpellier, France., Damier P; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, CIC 1413, Nantes University Hospital, Nantes University, INSERM, Nantes, France., Anheim M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, U964/UMR7104, Strasbourg Institute of Neuroscience, Strasbourg, France.; Strasbourg University Hospital, University of Strasbourg, INSERM, CNRS, Strasbourg, France., Marquès A; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, UMR 6602, Clermont-Ferrand University Hospital, CNRS, Clermont-Ferrand, France., Viallet F; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Aix-en-Provence Hospital, Aix-en-Provence, France., Giroud M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Dijon University Hospital, Dijon, France., Lefaucheur R; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Rouen University Hospital, Rouen, France., Costentin G; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Rouen University Hospital, Rouen, France., Spampinato U; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.; INCIA-UMR 5287, CNRS, University of Bordeaux, Bordeaux, France., Samier-Foubert A; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France., Carrière N; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France., Mutez E; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France., Mariani LL; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre, Sorbonne Université, Paris Brain Institute - ICM, Assistance-Publique Hôpitaux de Paris, INSERM, CNRS, Paris, France., Eusebio A; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Pathology of Movement, Parkinson Expert Centre, UMR7289, AP-HM-Timone Hospital, University of Aix-Marseille, CNRS, Marseille, France., Prange S; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Lyon Neuroscience Research Centre, PATH-PARK Team U1028, UMR5292, Bron, France., Benatru I; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre CIC1402, Poitiers University Hospital, INSERM, University of Poitiers, Poitiers, France., Charif M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Geriatrics, Parkinson Expert Centre, Clinical Investigation Centre CIC 1411, CHU Montpellier, INSERM, Montpellier, France., Brefel-Courbon C; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Fabbri M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Galitzky M; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Rousseau V; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Saubion A; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Catala H; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Ferreira JJ; Department of Clinical Pharmacology, Lisbon School of Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal and CNS - Campus Neurológico, Torres Vedras, Portugal., Burn DJ; Faculty of Medical Sciences, Newcastle University, The Medical School, Newcastle upon Tyne, UK., Corvol JC; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre, Sorbonne Université, Paris Brain Institute - ICM, Assistance-Publique Hôpitaux de Paris, INSERM, CNRS, Paris, France. |
